Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound

被引:36
|
作者
Klawe, C. [1 ]
Maschke, M. [1 ]
机构
[1] Bruederkrankenhaus Trier, Dept Neurol & Neurophysiol, D-54292 Trier, Germany
关键词
Alzheimer's disease; Creutzfeld-Jakob disease; flupirtine; G-protein-activated inwardly rectifying K+ channels (GIRKs); Kv7; channels; multiple sclerosis; muscle; pain; potassium channels; selective neuronal potassium channel openers (SNEPCO); spasticity; METHYL-D-ASPARTATE; ORAL FLUPIRTINE; MUSCLE TONE; BACK-PAIN; EFFICACY; PHARMACOKINETICS; CHANNELS; MALEATE; RAT; BIOTRANSFORMATION;
D O I
10.1517/14656560902988528
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Flupirtine is a nonopioid drug without antipyretic or antiphlogistic properties and with a favorable tolerability. It constitutes a unique class within the group of nonsteroidal analgesics and displays a peculiar pharmacodynamic profile that invites the investigation of applications beyond the pain-relieving effect. Objective: This review describes and evaluates the pharmacologic and clinical literature regarding flupirtine and discusses its future potential. Methods: A search of the primary literature and conference abstracts was conducted using the keyword 'flupirtine'. Resulting articles were compiled and analyzed for this review. Results/conclusions: Although flupirtine has gained a firm place in the treatment of acute and chronic pain in various clinical settings since its introduction, a broader range of applications remains to be explored in clinical trials. Possible neuroprotective effects due to N-methyl-D-aspartate antagonistic proper-ties of flupirtine might be promising in the treatment of Creutzfeld-Jakob disease, Alzheimer's disease, and multiple sclerosis. Trials in these fields are forthcoming.
引用
下载
收藏
页码:1495 / 1500
页数:6
相关论文
共 50 条